CD164 human
SIGMA/5100 - recombinant, expressed in E. coli, 0.5 mg protein/mL
Product Type: Chemical
| accession no. | NP_006007 |
| assay | ≥90% (SDS-PAGE) |
| biological source | human |
| concentration | 0.5 mg protein/mL |
| description | 0.05 mg of recombinant human CD164 in 20 mM Tris-HCl buffer, containing NaCl, KCl, EDTA, L-arginine, DTT and glycerol. |
| form | liquid |
| packaging | pkg of 50 μg |
| recombinant | expressed in E. coli |
| sterility | Filtered sterilized solution |
| storage temp. | −20°C |
| UniProt accession no. | Q04900   |
| Application: | Coating a plate well (6 well plate) with this recombinant CD164 matrix protein in HSC cell specific medium at 1-10 μg/well allows for human HSC / receptor interaction studies in vitro. Use this procedure as a guideline to determine optimal coating conditions for the culture system of choice. 1. Thaw CD164 and dilute to desired concentration using serum-free medium or PBS. The final solution should be sufficiently dilute so the volume added covers the surface evenly (1-10 μg/well, 6 well plate). Note: Use 1 ml PBS per well in a 6-well plate. 2. Add 1 - 10 μg protein to each well and incubate at 2 to 10 °C overnight. 3. After incubation, aspirate remaining material. 4. Plates are ready for use. They may also be stored at 2-8 °C damp or air dried if sterility is maintained |
| Preparation Note: | The full-length extracellular domain of the human CD164 cDNA (24 - 162 aa) was constructed with 29 N-terminal T7/HIS-tag and expressed in E. coli as inclusion bodies. The final product was refolded using a unique “temperature shift inclusion body refolding” technology and chromatographically purified as soluble protein. |
| Sequence: | MASMTGGQQMGRGHHHHHHGNLYFQ |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥90% (SDS-PAGE) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |